Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis

Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis

Background: This study aims to assess the effectiveness and safety of cefiderocol in treating severe infections caused by multidrug-resistant Gram-negative bacteria (MDR-GNB) in critically ill patients, particularly those in intensive care units (ICUs). Methods: A meta-analysis of studies, including...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Risco-Risco, César Henriquez-Camacho, Marta Herrera-Rueda, José Barberán, David Andaluz-Ojeda
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Antibiotics
Subjects:
severe infections
cefiderocol
<i>Acinetobacter baumannii</i>
critically ill
ICU
MDR
Online Access:https://www.mdpi.com/2079-6382/13/11/1048
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2079-6382/13/11/1048

Similar Items